Estimation of Utility Weights for Prostate-related Health States in Korea

키워드

참고문헌 (40)

1. Jemal A, "Annual report to the nation on the status of cancer, 1975-2014, featuring survival", J Natl Cancer Inst, 109(9), pp.djx030~ (2017)
2. Jemal A, "Cancer statistics, 2009", CA Cancer J Clin, 59(4), pp.225~249 (2009)
3. Center MM, "International variation in prostate cancer incidence and mortality rates", Eur Urol, 61(6), pp.1079~1092 (2012)
4. 원영주, "Geographical Variations and Trends in Major Cancer Incidences throughout Korea during 1999-2013", Cancer Research and Treatment, 50(4), pp.1281~1293 (2018), 대한암학회
5. Kimura T, "Epidemiology of prostate cancer in Asian countries", Int J Urol, 25(6), pp.524~531 (2018)
6. Cronin KA, "Annual report to the nation on the status of cancer, part I: national cancer statistics", Cancer, 124(13), pp.2785~2800 (2018)
7. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
8. 이광식, "Economic Burden of Cancer in Korea during 2000-2010", Cancer Research and Treatment, 47(3), pp.387~398 (2015), 대한암학회[DOI]
9. 이영주, "Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea", Investigative and Clinical Urology, 57(6), pp.424~430 (2016), 대한비뇨의학회[DOI]
10. Robert G, "Epidemiology of benign prostatic hyperplasia", Prog Urol, 28(15), pp.803~812 (2018)
11. 박현준, "Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS", BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil, 2013, pp.31(3), 193~207[DOI]
12. Roehrborn CG, "Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia(LUTS", BPH)combined responders to tadalafil after 12 weeks of treatment, 2016, pp.118(1), 153~160
13. Glina S, "Lower urinary tract symptoms and erectile dysfunction are highly prevalent in ageing men", BJU Int, 97(4), pp.763~765 (2006)
14. Morant S, "Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms", J Sex Med, 6(4), pp.1103~1110 (2009)
15. Rosen RC, "Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies : results from the BPH Registry", Urology, 73(3), pp.562~566 (2009)
16. Dolan P, "Valuing health states : a comparison of methods", J Health Econ, 15(2), pp.209~231 (1996)
17. Whitehead SJ, "Health outcomes in economic evaluation : the QALY and utilities", Br Med Bull, 96, pp.5~21 (2010)
18. Drummond MF, "Methods for the economic evaluation of health care programmes", pp.147~173 (2005), Oxford University Press
19. Torrance GW, "Social preferences for health states : an empirical evaluation of three measurement techniques", Socioecon Plann Sci, 10(3), pp.129~136 (1976)
20. Wee HL, "Validity, feasibility and acceptability of time trade-offand standard gamble assessments in health valuation studies: a study in a multiethnic Asian population in Singapore", Value Health, 11(Suppl 1), pp.S3~S10 (2008)
21. Kim SH, "Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-offtechniques in Korean population", Qual Life Res, 26(12), pp.3387~3397 (2017)
22. Bleichrodt H, "Standard gamble, time trade-offand rating scale: experimental results on the ranking properties of QALYs", J Health Econ, 16(2), pp.155~175 (1997)
23. Torrance GW, "Measurement of health state utilities for economic appraisal", J Health Econ, 5(1), pp.1~30 (1986)
24. Torrance GW, "Visual analog scales : do they have a role in the measurement of preferences for health states", Med Decis Making, 21(4), pp.329~334 (2001)
25. Bremner KE, "A review and meta-analysis of prostate cancer utilities", Med Decis Making, 27(3), pp.288~298 (2007)
26. Norman R, "International comparisons in valuing EQ-5D health states : a review and analysis", Value Health, 12(8), pp.1194~1200 (2009)
27. Wittenberg E, "The effect of age, race and gender on preference scores for hypothetical health states", Qual Life Res, 15(4), pp.645~653 (2006)
28. 김윤희, "한국에서 전립샘암 병기별․치료시기별 삶의 질", 보건경제와 정책연구, 19(2), pp.1~20 (2013), 한국보건경제정책학회
29. Kim SH, "Estimation of health state utilities in breast cancer", Patient Prefer Adherence, 11, pp.531~536 (2017)
30. "Appropriate perspectives for health care decisions" (2010)[URL]
31. 조민우, "EQ-5D 건강상태에 대한 가치 평가 작업의 타당도와 신뢰도 평가: 컴퓨터 보조프로그램을 이용한 표준도박", Korean Journal of Health Promotion, 10(3), pp.105~112 (2010), 대한임상건강증진학회
32. Krahn M, "Patient and community preferences for outcomes in prostate cancer : implications for clinical policy", Med Care, 41(1), pp.153~164 (2003)
33. Gries KS, "Utility estimates of disease-specific health states in prostate cancer from three different perspectives", Appl Health Econ Health Policy, 15(3), pp.375~384 (2017)
34. Torvinen S, "Health-related quality of life in prostate cancer", Acta Oncol, 52(6), pp.1094~1101 (2013)
35. Bergius S, "Health-related quality of life among prostate cancer patients : real-life situation at the beginning of treatment", Scand J Urol, 51(1), pp.13~19 (2017)
36. Krahn MD, "Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy", Prostate Cancer Prostatic Dis, 12(4), pp.361~368 (2009)
37. Smith KJ, "Quality-of-life utility values for erectile function and sildenafil treatment", Clin Drug Investig, 25(2), pp.99~105 (2005)
38. Postulart D, "Response shift and adaptation in chronically ill patients", Med Decis Making, 20(2), pp.186~193 (2000)
39. Pickard AS, "Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients", Med Care, 45(3), pp.259~263 (2007)
40. Morimoto T, "Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals", J Epidemiol, 12(2), pp.160~178 (2002)

관련 논문AI추천